On the other hand, we found that the hepatic triglyceride content was increased in HFD, which is a typical finding of NAFLD24, and this was significantly decreased by ANP-treatment (Fig. 3e), reflecting the finding that ANP treatment ameliorated hepatic steatosis. The gene discussed is NPPA; the disease is fatty liver disease.